The Safety of Continuous Infusion Propofol in Mechanically Ventilated Adults With Coronavirus Disease 2019.

Corey J WitenkoAudrey J LittlefieldSajjad AbedianAnjile AnPhilip S BarieKaren Berger

Published in: The Annals of pharmacotherapy (2021)

Hypertriglyceridemia occurred frequently in patients with COVID-19 who received propofol but did not lead to acute pancreatitis. Elevated triglyceride concentrations occurred more often and at lower cumulative doses than previously reported in patients without COVID-19. Application of these data may aid in optimal monitoring for serious adverse effects of propofol in patients with COVID-19.

Keyphrases

coronavirus disease
end stage renal disease
sars cov
newly diagnosed
ejection fraction
peritoneal dialysis
chronic kidney disease
intensive care unit
prognostic factors
acute respiratory distress syndrome
respiratory syndrome coronavirus
emergency department
adverse drug